Oncology Journal Issues Research Articles in September 2022 Edition
September 16, 2022
September 16, 2022
CHICAGO, Illinois, Sept. 16 -- JAMA Oncology, an international peer-reviewed journal for scientists, clinicians and trainees in the field of oncology from the American Medical Association, published research articles on the following topics in its September 2022 edition:
Original Investigations:
* Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomize . . .
Original Investigations:
* Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomize . . .